menu
    • menu

    Company profile for Sagimet Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are focused on blocking fatty acid synthase (FASN) a key regulator of lipid synthesis, FASN activity is increased in certain diseases such as in the liver of patients with NASH and in certain tumor types. We believe that FASN provides an intervention point for clinical benefit. Our lead product candidate, TVB-2640, is an oral, highly potent, selective and reversible, first-in-class inhibitor of FASN in clinical developme...
    We are focused on blocking fatty acid synthase (FASN) a key regulator of lipid synthesis, FASN activity is increased in certain diseases such as in the liver of patients with NASH and in certain tumor types. We believe that FASN provides an intervention point for clinical benefit. Our lead product candidate, TVB-2640, is an oral, highly potent, selective and reversible, first-in-class inhibitor of FASN in clinical development. Phase 1 clinical studies showed that TVB-2640 inhibits de novo lipogenesis in cancer patients and reduces liver fat synthesis in people with characteristics of metabolic syndrome.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sagimet BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    155 Bovet Road, Suite 303 San Mateo, CA 94402
    Telephone
    Telephone
    +1 650.561.8600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sagimet.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascletis Accepts Denifanstat NDA For Moderate To Severe Acne
    Ascletis Accepts Denifanstat NDA For Moderate To Severe Acne

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203051/0/en/Sagimet-s-License-Partner-Ascletis-Announced-Acceptance-of-New-Drug-Application-for-Denifanstat-for-the-Treatment-of-Moderate-to-Severe-Acne-by-China-s-National-Medical-Products-Ad.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Sagimet Biosciences to Participate in 8th Evercore ISI Conference
    Sagimet Biosciences to Participate in 8th Evercore ISI Conference

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191757/0/en/Sagimet-Biosciences-to-Participate-in-the-8th-Annual-Evercore-ISI-Healthcare-Conference.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Sagimet Biosciences Reveals Q3 2025 Financials And Corporate News
    Sagimet Biosciences Reveals Q3 2025 Financials And Corporate News

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187191/0/en/Sagimet-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Sagimet Biosciences Showcases Two Denifanstat Posters at AASLD
    Sagimet Biosciences Showcases Two Denifanstat Posters at AASLD

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184391/0/en/Sagimet-Biosciences-Presents-Two-Denifanstat-Posters-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Denifanstat Meets All Ph3 Endpoints in Moderate to Severe Acne
    Denifanstat Meets All Ph3 Endpoints in Moderate to Severe Acne

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172712/0/en/Denifanstat-Achieved-All-Endpoints-in-the-Treatment-of-Moderate-to-Severe-Acne-in-Phase-3-Clinical-Trial-in-Acne-in-China-A-Presentation-at-the-2025-Fall-Clinical-Dermatology-Confe.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Sagimet Biosciences To Participate In 3 Investor Conferences
    Sagimet Biosciences To Participate In 3 Investor Conferences

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166010/0/en/Sagimet-Biosciences-Announces-Participation-in-Three-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search